SPTXSeaport Therapeutics, Inc.
$18.14
$18.14
$15.2552 weeks$27.92
Price
End-of-day closes, not the intraday tick.
The five questions
2 of 5 availableOnly two of the five can be answered for SPTX today. The rest need figures this filer has not published. The tabs above still show whatever data does exist.
- Is the business good?not enough filed
- Is it safe?Watch
- Is the price fair?not enough filed
- Is it growing?not enough filed
- What is the market doing?Mixed
P/En/a
Market value$1.04B
1 yearn/a
5 yearsn/a
Charts
As reported to the SEC, without any scoring.
The next results filing is expected around Nov 2, 2026, a quarter after the last one.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 3, 2026Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress.Earnings release · press release
- Jun 8, 2026Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress.Earnings release · press release
- May 4, 2026Amendments to Articles of Incorporation or Bylaws As previously disclosed in the Registration Statement on Form S-1, as amended (File No. 333-294976) (the “Registration Statement”) of Seaport Therapeutics, Inc. (the “Company”) and in connection with the consummation of the initial public offering of the Company’s …Charter/bylaw amendment or fiscal-year change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Biotechnology
The closest names by size in the same industry